Share Name Share Symbol Market Type Share ISIN Share Description
Smith & Nephew Plc LSE:SN. London Ordinary Share GB0009223206 ORD USD0.20
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -3.00 -0.27% 1,115.50 1,115.50 1,116.00 1,118.00 1,103.00 1,117.00 1,826,907 16:10:38
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Health Care Equipment & Services 3,854.1 433.3 44.2 23.0 9,733

Smith & Nephew Plc Board Committee Membership

01/09/2022 7:02am

UK Regulatory (RNS & others)

Smith & Nephew (LSE:SN.)
Historical Stock Chart

From Jul 2022 to Jan 2023

Click Here for more Smith & Nephew Charts.


RNS Number : 8443X

Smith & Nephew Plc

01 September 2022

1 September 2022

Board Committee Membership

Smith & Nephew plc (LSE:SN, NYSE:SNN) announces that the Board has resolved to appoint Jo Hallas, Independent Non-Executive Director, as a member of the Audit Committee and Angie Risley, Independent Non-Executive Director, as a member of the Nomination & Governance Committee. Both appointments are effective 1 September 2022.

This announcement has been made in accordance with the requirements of 9.6.11(3) of the Listing Rules.


Andrew Swift                       +44 (0) 1923 477433 
Charles Reynolds                   +44 (0) 1923 477314 
Susan Gilchrist / Ayesha Bharmal   +44 (0) 20 7404 5959 

About Smith+Nephew

Smith+Nephew is a portfolio medical technology company that exists to restore people's bodies and their self-belief by using technology to take the limits off living. We call this purpose 'Life Unlimited'. Our 18,000 employees deliver this mission every day, making a difference to patients' lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global franchises of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.

Founded in Hull, UK, in 1856, we now operate in more than 100 countries, and generated annual sales of $5.2 billion in 2021. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms 'Group' and 'Smith+Nephew' are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.

For more information about Smith+Nephew, please visit and follow us on Twitter ,

LinkedIn ,   Instagram   or   Facebook . 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.



(END) Dow Jones Newswires

September 01, 2022 02:02 ET (06:02 GMT)

1 Year Smith & Nephew Chart

1 Year Smith & Nephew Chart

1 Month Smith & Nephew Chart

1 Month Smith & Nephew Chart
Your Recent History
Smith & Ne..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20230131 16:25:43